Allison Deangelis is a reporter for STAT, with a focus on covering various topics within the biotech industry. Her articles provide in-depth analysis and insights into the latest developments, trends, and key players in the field. Allison's work has also been featured in the Boston Globe Technology section.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Allison Deangelis focuses on the healthcare and pharmaceutical industry, particularly biotechnology. Her articles often include press releases, private sector announcements, data citations, and expert commentary.
To effectively reach out to Allison Deangelis, consider providing insights or access to individuals with expertise in cutting-edge biotechnological developments such as gene therapy, novel drug discoveries for conditions like obesity or cancer treatment. Pitches could also involve exclusive interviews with key figures in startups and established companies within the biotech space.
As Allison's geographic focus is not specified but her coverage seems international in nature due to its emphasis on major industry events and global players within the healthcare and pharmaceutical sectors.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Adam Feuerstein, Allison Deangelis
On STAT's podcast, hear about what’s in store for biotech VCs in 2025, Pfizer's new head of R&D, drug innovation in a second Trump term, and more.
By: Allison DeAngelis, Jonathan Wosen, Adam Feuerstein, Lizzy, Lawrence
By: Allison Deangelis, Adam Feuerstein
STAT reporters Helen Branswell and Allison DeAngelis give updates, respectively, on bird flu and radiopharmaceuticals.
By: Elaine Chen, Allison DeAngelis, Adam Feuerstein
By: Adam Feuerstein, Elaine Chen, Allison DeAngelis
(833) 317-6278 
